Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study” - Scorecard - MDSpire

Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

  • August 26, 2025

  • 0 min

Share

Clinical Scorecard: Erratum: Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Patients with Type 2 Diabetes - Insights from a Real-World Analysis

At a Glance

CategoryDetail
ConditionNot applicable (Erratum regarding authorship and funding corrections)
Key MechanismsNot applicable
Target PopulationNot applicable
Care SettingNot applicable

Key Highlights

  • Correction of hyphenation in author names Benaya Rozen-Zvi and Anat Gafter-Gvili.
  • Correction of author name hyphenation in the Funding section.
  • Original article has been corrected online to reflect these changes.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

            References

            Original Source(s)

            Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

            • August 26, 2025

            Related Content

            Experts question diet guidelines' higher protein-intake advice

            Diabetes Risk Scores: Beyond Glucose

            Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

            Correction to: “Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors”

            • February 9, 2026